Tesamorelin
GHRH analogue, Egrifta
Mechanism
Full-length GHRH analogue. Stimulates pituitary somatotroph cells to release GH. More potent than Sermorelin with a longer half-life. FDA-approved for HIV lipodystrophy.
Benefits
- ✓Increased GH and IGF-1 levels
- ✓Visceral fat reduction (clinically proven)
- ✓Improved body composition
- ✓Better sleep quality
- ✓Cognitive improvements in older adults
Dosing
1,000mcg/day SubQ. Usually injected before bed to align with natural GH pulsation.
Reconstitution
10mg + 2mL BAC = 5,000mcg/mL. Draw 20 units for 1,000mcg.
Cycle Length
Cycles of 3–6 months with 1–2 month breaks. Or continuous with regular IGF-1 monitoring.
Timing
Before bed (30 min before sleep) on empty stomach for best results.
Stacks Well With
Ipamorelin (synergistic stack), CJC-1295
Cautions
Can elevate IGF-1. Monitor IGF-1 levels quarterly. Avoid with active cancer.